AstraZeneca’s R&D organisation is headquartered in Södertälje, situated south-west of Stockholm, Sweden’s capital city and includes one of the world’s most advanced biotechnology laboratories. 

Research here is focused mainly in the neuroscience area – developing new products for pain control and for treating disorders of the central nervous system.

Over 1,600 people from all disciplines work in research and development at Södertälje, where we employ over 8,000 people in total.

Read more about this facility. 

Take a 360° tour of this facility.